Solid Tumors
Solid tumors are abnormal masses of tissue that can occur in various organs and are characterized by the presence of cancerous cells. They can be benign or malignant and often require surgical intervention.
CRISPR CAR Therapy for Blood and Solid Cancers
We are studying the long-term safety and effectiveness of CRISPR CAR cellular therapies in patients with hematological and solid malignancies. This research aims to provide insights into how well this treatment works over time.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Hematologic Malignancies
Hematologic malignancies are cancers that affect the blood, bone marrow, and lymph nodes. They include conditions like leukemia, lymphoma, and myeloma, and can disrupt normal blood cell production.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Have you received CRISPR CAR cellular therapy?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
University Medical Center Hamburg-Eppendorf
Klinik für Stammzelltransplantation
Hamburg, Germany
Sponsor: CRISPR Therapeutics AG
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.